Corcept Therapeutics (CORT) Gross Profit (2012 - 2026)
Corcept Therapeutics' Gross Profit came in at $335.86 million for Q3 2026, up 65.4% from $203.04 million a year earlier and up 33.2% from the prior quarter.
Corcept Therapeutics (CORT) Gross Profit (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Corcept Therapeutics reported Gross Profit of $949.55 million, up 30.5% year-over-year; for FY2025, it came in at $748.43 million, up 12.7% from FY2024.
- Gross Profit has increased in each of the last 13 years, with a five-year compound annual growth rate of 16.5% (FY2020 to FY2025).
- Going back by year, Gross Profit was $664.16 million in FY2024 (+39.6%), $475.89 million in FY2023 (+20.0%), $396.47 million in FY2022 (+9.9%) and $360.7 million in FY2021 (+3.6%).
- The Q3 2026 figure represents the highest quarterly Gross Profit in data going back to Q2 2012.
- Year-over-year, Gross Profit has increased for 22 consecutive quarters, with growth averaging 23.3% over the last eight quarters.
- Across the past five years, year-over-year growth in Gross Profit ran from 4.2% in Q4 2022 to 65.4% in Q3 2026.
- Business Quant data shows CORT's Gross Profit at $252.09 million (Q2 2026), $162.02 million (Q1 2026) and $199.58 million (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Corcept Therapeutics | 7.99 Bn | 6.60 Bn | 335.86 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 335.86 Mn |
| Jun 30, 2026 | 252.09 Mn |
| Mar 31, 2026 | 162.02 Mn |
| Dec 31, 2025 | 199.58 Mn |
| Sep 30, 2025 | 203.04 Mn |
| Jun 30, 2025 | 191.00 Mn |
| Mar 31, 2025 | 154.81 Mn |
| Dec 31, 2024 | 178.93 Mn |
| Sep 30, 2024 | 179.68 Mn |
| Jun 30, 2024 | 161.27 Mn |
| Mar 31, 2024 | 144.27 Mn |
| Dec 31, 2023 | 133.53 Mn |
| Sep 30, 2023 | 121.96 Mn |
| Jun 30, 2023 | 116.14 Mn |
| Mar 31, 2023 | 104.27 Mn |
| Dec 31, 2022 | 101.58 Mn |
| Sep 30, 2022 | 100.39 Mn |
| Jun 30, 2022 | 102.07 Mn |
| Mar 31, 2022 | 92.44 Mn |
| Dec 31, 2021 | 97.47 Mn |
Corcept Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=CORT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();